Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Preusser

Showing results (101-110 of 525) with videos related to

Pageof 53
Sort By:
American Journal of Clinical Pathology|September 9, 2005
Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcomeMatthias Preusser, Stefan Wolfsberger, Thomas Czech, et al.
Journal of Neuropathology and Experimental Neurology|June 28, 2005
Visualization of Central European tick-borne encephalitis infection in fatal human casesEllen Gelpi, Matthias Preusser, Ferenc Garzuly, et al.
Nature Reviews. Neurology|August 12, 2015
Prospects of immune checkpoint modulators in the treatment of glioblastomaMatthias Preusser, Michael Lim, David A Hafler, et al.
Neuro-Oncology Advances|March 9, 2026
Drawing parallels between amyloid PET in Alzheimer's disease and amino acid PET in primary and secondary brain tumorsNelleke Tolboom, Antoine Verger, Matthias Preusser, et al.
Cancer Treatment Reviews|March 23, 2024
The more the merrier? Evidence and efficacy of immune checkpoint- and tyrosine kinase inhibitor combinations in advanced solid cancersAngelika M Starzer, Ladislaia Wolff, Petar Popov, et al.
Clinical Neuropathology|April 27, 2013
Clinical neuropathology practice guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkersAnna S Berghoff, Harald Stefanits, Adelheid Woehrer, et al.
Biomarkers in Medicine|June 17, 2015
Erratum. Plasma fibrinogen and blood platelet counts are associated with response to neoadjuvant therapy in esophageal cancerAysegül Ilhan-Mutlu, Patrick Starlinger, Thomas Perkmann, et al.
Anticancer Research|February 5, 2009
mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivoDaniel Cejka, Matthias Preusser, Thorsten Fuereder, et al.
Anticancer Research|February 5, 2020
Utilization and Efficacy of Palliative Chemotherapy for Locally Advanced or Metastatic Gastroesophageal CarcinomaRuth Baumgartner, Hossein Taghizadeh, Gerd Jomrich, et al.
Cancers|March 29, 2023
Recent Advances in the Systemic Treatment of Localized Gastroesophageal CancerHannah Christina Puhr, Thorsten J Reiter, Matthias Preusser, et al.
Pageof 53

Showing results (101-110 of 525) with videos related to

Sort By:
Pageof 53
American Journal of Clinical Pathology|September 9, 2005
Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcomeMatthias Preusser, Stefan Wolfsberger, Thomas Czech, et al.
Journal of Neuropathology and Experimental Neurology|June 28, 2005
Visualization of Central European tick-borne encephalitis infection in fatal human casesEllen Gelpi, Matthias Preusser, Ferenc Garzuly, et al.
Nature Reviews. Neurology|August 12, 2015
Prospects of immune checkpoint modulators in the treatment of glioblastomaMatthias Preusser, Michael Lim, David A Hafler, et al.
Neuro-Oncology Advances|March 9, 2026
Drawing parallels between amyloid PET in Alzheimer's disease and amino acid PET in primary and secondary brain tumorsNelleke Tolboom, Antoine Verger, Matthias Preusser, et al.
Cancer Treatment Reviews|March 23, 2024
The more the merrier? Evidence and efficacy of immune checkpoint- and tyrosine kinase inhibitor combinations in advanced solid cancersAngelika M Starzer, Ladislaia Wolff, Petar Popov, et al.
Clinical Neuropathology|April 27, 2013
Clinical neuropathology practice guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkersAnna S Berghoff, Harald Stefanits, Adelheid Woehrer, et al.
Biomarkers in Medicine|June 17, 2015
Erratum. Plasma fibrinogen and blood platelet counts are associated with response to neoadjuvant therapy in esophageal cancerAysegül Ilhan-Mutlu, Patrick Starlinger, Thomas Perkmann, et al.
Anticancer Research|February 5, 2009
mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivoDaniel Cejka, Matthias Preusser, Thorsten Fuereder, et al.
Anticancer Research|February 5, 2020
Utilization and Efficacy of Palliative Chemotherapy for Locally Advanced or Metastatic Gastroesophageal CarcinomaRuth Baumgartner, Hossein Taghizadeh, Gerd Jomrich, et al.
Cancers|March 29, 2023
Recent Advances in the Systemic Treatment of Localized Gastroesophageal CancerHannah Christina Puhr, Thorsten J Reiter, Matthias Preusser, et al.
Pageof 53